×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by MENDLEIN JOHN

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorJan 19, 2023Option Exercise$1.3728,46138,992311,231Jan 20, 2023, 04:14 PM
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorJan 11, 2023Buy$5.6788,048499,232246,139Jan 13, 2023, 06:20 PM
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorJan 13, 2023Buy$5.4336,631198,906282,770Jan 13, 2023, 06:20 PM
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorJun 03, 2022Sale$22.791,36431,086158,091Jun 06, 2022, 04:49 PM
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorMar 10, 2022Sale$18.3263,1241,156,646191,017Mar 11, 2022, 04:58 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorDec 21, 2018Buy$0.42195,00082,602615,382Dec 26, 2018, 04:15 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNDirectorDec 20, 2018Buy$0.4150,00020,645420,382Dec 26, 2018, 04:15 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorAug 31, 2017Buy$2.6537,736100,000367,883Sep 05, 2017, 07:41 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorApr 24, 2017Buy$3.00124372327,647Apr 26, 2017, 05:02 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorApr 18, 2017Buy$3.001,0003,000325,971Apr 20, 2017, 07:04 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorApr 20, 2017Buy$3.001,5524,656327,523Apr 20, 2017, 07:04 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorDec 19, 2016Buy$2.2069,000151,662324,971Dec 21, 2016, 11:54 AM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorApr 05, 2016Buy$3.522,5008,800250,971Apr 07, 2016, 03:25 PM
LIFEaTYR PHARMA INCMENDLEIN JOHNCEO and DirectorApr 05, 2016Buy$3.552,5008,875248,471Apr 06, 2016, 07:19 PM
FATEFATE THERAPEUTICS INCMENDLEIN JOHNDirectorOct 04, 2013Buy$6.0016,667100,002156,774Oct 07, 2013, 01:59 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe